PadeliporfinAlternative Names: Palladium bacteriopheophorbide; Pd-bacteriopheophorbide; Pd-Bpheid; Tookad; WST-09; WST09 cpd
Latest Information Update: 14 Jun 2010
At a glance
- Originator STEBA France
- Class Antineoplastics; Porphyrins; Small molecules
- Mechanism of Action Photosensitisers; Vascular disrupting agents
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Prostate cancer
Most Recent Events
- 31 May 2006 Phase-II/III clinical trials in Prostate cancer in Canada (IV)